Circassia Group Plc
- Jurisdiction
United Kingdom - LEI
2138006YAT138TOGA556 - ISIN
GB00BJVD3B28 (CIR.L )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€1.13 41.3% undervalued - Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€90.44M - Gross margin
69.5% - EBIT
€14.15M - EBIT margin
15.6% - Net income
€15.19M - Net margin
16.8%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
No dividend payouts
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Áinne Naylor | PCA of Robert Naylor (Non-Executive Director) |
|
|
|
|